AGM Report

Ergomed (ERGO) AGM 2018

AGM Date: June 19, 2018

Report Author: Tim Grattan

This year’s Ergomed AGM was held at the offices of Covington & Burling LLP, 265 Strand, London WC2R 1BH starting at 9.30am on Tuesday 12 June 2018. For Investors who are unfamiliar with the company, Ergomed is a hybrid Pharmaceutical Services company offering a complete Clinical Development service for investigational drugs and a Pharmacovigilance (PV) monitoring service for marketed products. What makes Ergomed fairly unique amongst its peers is its co-development model, whereby it shares the cost of clinical trials on new medicines that it runs on behalf of clients, in exchange for a royalty (typically 10 – 15%) on sales. Ergomed was founded in 1997 and listed on AIM in July 2014 raising £11m at 160p/share valuing the company at £46m. The number of shares has increased from 28.75m

...

Not a member? Join today

Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:

Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities

Join now